From: Diverse regulatory manners of human telomerase reverse transcriptase
Enzyme | Site | Effects on hTERT/telomerase | Human cell model | Ref. |
---|---|---|---|---|
PTMs: Phosphorylation | ||||
 AKT | Ser 824 | telomerase activity ↑ | melanoma cells | [149] |
 AKT | Ser 227 | hTERT nuclear translocation ↑ cell immortalization ↑ | lung carcinoma cells and foreskin fibroblast cells | [150] |
 AKT | Ser 227 | hTERT binding with importin-α ↑ hTERT nuclear import ↑ telomerase activity ↑ | breast cancer cells | [151] |
 PKCα, β, δ, ε, ζ | Unclear | hTERT association with HSP90 ↑ telomerase holoprotein integrity ↑ telomerase activation ↑ chemosensitivity to cisplatin ↓ | head and neck cancer cells | [152] |
 PKCα | Unclear | telomerase activity ↑ | breast cancer cells | [153] |
 SRC | Tyr 707 | cytoplasm translocation ↑ antiapoptotic function ↑ | embryonic kidney cells | [154] |
 SRC | Tyr 707 | mitochondrial hTERT ↓ | umbilical and vein endothelial cells | [155] |
 c-ABL | Tyr | telomerase activity ↓ | embryonic kidney cells and breast cancer cells | [157] |
 Unclear | Unclear | nuclear translocation ↑ | CD4+ T cells | [158] |
PTMs: Dephosphorylation | ||||
 SHP-2 | Tyr 707 | SRC kinase function↓ H2O2-induced hTERT nuclear export ↓nuclear telomerase activity ↑ | endothelial cells | [156] |
PTMs: Ubiquitination | ||||
 MKRN1 | Unclear | hTERT degradation ↑ telomerase activity ↓ telomere length ↓ | lung carcinoma cells | [161] |
 HDM2 | N-Lys 78, 94, 236, 339, 348 | hTERT degradation ↑ protection against apoptosis ↓ | colon cancer, lung carcinoma, osteosarcoma and embryonic kidney cells | [162] |
 CHIP | Unclear | hTERT associating with p23 ↓ hTERT nuclear translocation ↓ hTERT degradation ↑ | lung carcinoma cells | [163] |